These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23997027)

  • 1. Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.
    McDonald TO; Giardiello M; Martin P; Siccardi M; Liptrott NJ; Smith D; Roberts P; Curley P; Schipani A; Khoo SH; Long J; Foster AJ; Rannard SP; Owen A
    Adv Healthc Mater; 2014 Mar; 3(3):400-11. PubMed ID: 23997027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving maraviroc oral bioavailability by formation of solid drug nanoparticles.
    Savage AC; Tatham LM; Siccardi M; Scott T; Vourvahis M; Clark A; Rannard SP; Owen A
    Eur J Pharm Biopharm; 2019 May; 138():30-36. PubMed ID: 29777772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
    Tshweu L; Katata L; Kalombo L; Chiappetta DA; Hocht C; Sosnik A; Swai H
    Nanomedicine (Lond); 2014; 9(12):1821-33. PubMed ID: 24364871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading.
    Shen H; Banerjee AA; Mlynarska P; Hautman M; Hong S; Kapetanovic IM; Lyubimov AV; Liu Y
    J Pharm Sci; 2012 Oct; 101(10):3877-85. PubMed ID: 22821759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation.
    Kotta S; Khan AW; Ansari SH; Sharma RK; Ali J
    Int J Pharm; 2014 Feb; 462(1-2):129-34. PubMed ID: 24374067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
    Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].
    Chiappetta DA; Hocht C; Taira C; Sosnik A
    Nanomedicine (Lond); 2010 Jan; 5(1):11-23. PubMed ID: 20025460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
    Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
    Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles.
    Chiappetta DA; Hocht C; Taira C; Sosnik A
    Biomaterials; 2011 Mar; 32(9):2379-87. PubMed ID: 21186055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo.
    Hari BNV; Narayanan N; Dhevendaran K; Ramyadevi D
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():522-532. PubMed ID: 27287151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs.
    Nkansah P; Antipas A; Lu Y; Varma M; Rotter C; Rago B; El-Kattan A; Taylor G; Rubio M; Litchfield J
    J Control Release; 2013 Jul; 169(1-2):150-61. PubMed ID: 23570985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W; Horn SW; Hussain MD
    Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.